Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C

Basic Research in Cardiology

Volumn 97, Issue 2, 2002, Pages 125-131

  Sindermann, Jürgen R ^a   Skaletz Rorowski, Adriane ^a   Bartels, Anke ^a   Hohage, Helge ^b   Plenz, Gabriele ^b   Schmidt, Annette ^a   Breithardt, Günter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Cyclosporine A; Paclitaxel; Protein kinase C; Restenosis; Vascular smooth muscle cells

Indexed keywords

CYCLOSPORIN A; DNA FRAGMENT; PACLITAXEL; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; THYMIDINE;

ANALYSIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATTLE; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY BLOOD VESSEL; DNA HISTONE INTERACTION; DNA SYNTHESIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MAXIMUM TOLERATED DOSE; NONHUMAN; PROTEIN INDUCTION; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CATTLE; CELL DIVISION; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY VESSELS; CYCLOSPORINE; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE AGENTS; MUSCLE, SMOOTH, VASCULAR; PACLITAXEL; PROTEIN KINASE C;

EID: 0036118857     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950200002     Document Type: Article

References (26)

1. Accelerated arteriosclerosis after transplantation: The possible role of calcium channel blockers
2. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery
3. Activation of NF-kB by antineoplastic agents
4. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent
5. Transplant atherosclerosis: The clinical syndrome, pathogenesis and possible model of spontaneous atherosclerosis
6. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis
7. In vivo role of the extracellular matrix during vascular repair
8. Effect of pravastatin on outcomes after cardiac transplantation
9. Direct and endothelial cell-mediated effect of cyclosporine A on the proliferation of rat smooth muscle cells in vitro
10. Women and heart disease
11. Coronary artery disease - Free radical damage, antioxidant protection and the role of homocysteine
12. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor
13. Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery
14. Inhibition of smooth muscle proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter
15. Cyclosporine A-induced contractions and prostacyclin release are maintained by extracellular calcium in rat aortic rings: Role of protein kinase C
16. Nifedipine, losartan and captopril effects on hyperplasia of vascular smooth muscle from Ren-2 transgenic rats
17. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells
18. Cyclosporine A enhances paclitaxel toxicity against leukemia and respiratory epithel cancers
19. The pathogenesis of atherosclerosis: A perspective of the 1990s
20. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; Final results of the fluvastatin angiographic restenosis (FLARE) trial
21. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture
22. Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways
23. Protein kinase C mediates basic fibroblast growth factor-induced proliferation through mitogen-activated protein kinase in coronary smooth muscle cells
24. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
25. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro
26. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin restenosis trial study group